Compare Piramal Healthcare with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs FDC LTD. - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES FDC LTD. PIRAMAL ENTERPRISES/
FDC LTD.
 
P/E (TTM) x 13.7 16.3 84.1% View Chart
P/BV x 0.9 2.2 39.5% View Chart
Dividend Yield % 2.0 0.0 -  

Financials

 PIRAMAL ENTERPRISES   FDC LTD.
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
FDC LTD.
Mar-18
PIRAMAL ENTERPRISES/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs3,303319 1,035.3%   
Low Rs1,797164 1,095.6%   
Sales per share (Unadj.) Rs716.561.6 1,162.3%  
Earnings per share (Unadj.) Rs79.79.9 801.1%  
Cash flow per share (Unadj.) Rs107.912.0 901.9%  
Dividends per share (Unadj.) Rs28.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs1,477.573.2 2,019.3%  
Shares outstanding (eoy) m184.45174.40 105.8%   
Bonus/Rights/Conversions ISBB-  
Price / Sales ratio x3.63.9 90.8%   
Avg P/E ratio x32.024.3 131.8%  
P/CF ratio (eoy) x23.620.2 117.1%  
Price / Book Value ratio x1.73.3 52.3%  
Dividend payout %35.10-   
Avg Mkt Cap Rs m470,29242,118 1,116.6%   
No. of employees `0007.85.5 141.4%   
Total wages/salary Rs m22,5042,167 1,038.6%   
Avg. sales/employee Rs Th16,899.41,943.7 869.4%   
Avg. wages/employee Rs Th2,877.7391.7 734.6%   
Avg. net profit/employee Rs Th1,879.9313.7 599.3%   
INCOME DATA
Net Sales Rs m132,15310,751 1,229.3%  
Other income Rs m3,128510 613.8%   
Total revenues Rs m135,28111,260 1,201.4%   
Gross profit Rs m66,2902,267 2,924.2%  
Depreciation Rs m5,202351 1,480.2%   
Interest Rs m44,09714 314,981.4%   
Profit before tax Rs m20,1192,411 834.4%   
Minority Interest Rs m3,194-5 -66,537.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,611671 1,283.0%   
Profit after tax Rs m14,7011,735 847.3%  
Gross profit margin %50.221.1 237.9%  
Effective tax rate %42.827.8 153.8%   
Net profit margin %11.116.1 68.9%  
BALANCE SHEET DATA
Current assets Rs m122,7427,213 1,701.8%   
Current liabilities Rs m310,8102,104 14,774.4%   
Net working cap to sales %-142.347.5 -299.5%  
Current ratio x0.43.4 11.5%  
Inventory Days Days2354 42.3%  
Debtors Days Days3928 140.1%  
Net fixed assets Rs m116,9046,865 1,702.9%   
Share capital Rs m369175 210.6%   
"Free" reserves Rs m272,16112,586 2,162.4%   
Net worth Rs m272,53012,761 2,135.6%   
Long term debt Rs m270,1966 4,503,270.0%   
Total assets Rs m856,26115,041 5,692.7%  
Interest coverage x1.5173.2 0.8%   
Debt to equity ratio x1.00 210,863.4%  
Sales to assets ratio x0.20.7 21.6%   
Return on assets %6.911.6 59.1%  
Return on equity %5.413.6 39.7%  
Return on capital %12.419.0 65.5%  
Exports to sales %012.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1,327 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m15,2001,889 804.7%   
Fx outflow Rs m4,8890-   
Net fx Rs m10,3121,889 545.9%   
CASH FLOW
From Operations Rs m-115,9751,498 -7,739.9%  
From Investments Rs m-8,265201 -4,109.9%  
From Financial Activity Rs m107,525-1,694 -6,346.3%  
Net Cashflow Rs m-16,65010 -161,652.4%  

Share Holding

Indian Promoters % 52.9 68.9 76.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 4.7 85.1%  
FIIs % 26.6 7.5 354.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 19.0 86.8%  
Shareholders   93,274 23,730 393.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   ELDER PHARMA  TTK HEALTHCARE  ORCHID PHARMA LTD  DISHMAN PHARMA  J.B.CHEMICALS  

Compare PIRAMAL ENTERPRISES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bajaj Finance and ICICI Bank Top Gainers(12:30 pm)

Stock markets in India are presently trading on a positive note. The BSE Sensex is trading up by 90 points and the NSE Nifty is trading up by 35 points.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Oct 16, 2019 01:19 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - SUN PHARMA COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS